DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,529,222 | +28.7% | 14,225 | +24.5% | 0.02% | +23.5% |
Q2 2023 | $2,742,720 | +46.0% | 11,428 | +53.3% | 0.02% | +54.5% |
Q1 2023 | $1,878,706 | +8.2% | 7,454 | +14.0% | 0.01% | +22.2% |
Q4 2022 | $1,735,847 | +0.1% | 6,540 | -2.6% | 0.01% | 0.0% |
Q3 2022 | $1,734,000 | -30.2% | 6,713 | -31.5% | 0.01% | -18.2% |
Q2 2022 | $2,485,000 | -76.0% | 9,803 | -72.2% | 0.01% | -73.8% |
Q1 2022 | $10,346,000 | +110.3% | 35,270 | +135.9% | 0.04% | +44.8% |
Q4 2021 | $4,919,000 | -97.7% | 14,950 | -97.9% | 0.03% | -97.5% |
Q3 2021 | $214,230,000 | -6.9% | 703,685 | -18.0% | 1.17% | -20.6% |
Q2 2021 | $230,221,000 | +130.9% | 857,883 | +93.7% | 1.48% | +68.0% |
Q1 2021 | $99,692,000 | +7.7% | 442,920 | +6.3% | 0.88% | +9.7% |
Q4 2020 | $92,578,000 | +149.2% | 416,757 | +141.5% | 0.80% | +79.2% |
Q3 2020 | $37,154,000 | +2210.6% | 172,543 | +820.5% | 0.45% | +3963.6% |
Q3 2017 | $1,608,000 | +13.0% | 18,745 | +12.7% | 0.01% | -31.2% |
Q1 2017 | $1,423,000 | -76.0% | 16,638 | -78.0% | 0.02% | -72.4% |
Q3 2016 | $5,926,000 | +168.1% | 75,600 | +245.4% | 0.06% | +107.1% |
Q2 2016 | $2,210,000 | -70.4% | 21,885 | -72.2% | 0.03% | -70.5% |
Q1 2016 | $7,474,000 | +1057.0% | 78,785 | +938.7% | 0.10% | +955.6% |
Q3 2015 | $646,000 | -66.3% | 7,585 | -66.1% | 0.01% | -50.0% |
Q2 2015 | $1,917,000 | -16.7% | 22,403 | -17.3% | 0.02% | 0.0% |
Q1 2015 | $2,301,000 | +13.7% | 27,103 | +14.8% | 0.02% | +12.5% |
Q4 2014 | $2,023,000 | +27.6% | 23,603 | +17.2% | 0.02% | +33.3% |
Q2 2014 | $1,586,000 | -65.4% | 20,139 | -67.0% | 0.01% | -67.6% |
Q1 2014 | $4,578,000 | – | 61,039 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |